Network meta-analysis with competing risk outcomes

Value in Health

Volumn 13, Issue 8, 2010, Pages 976-983

  Ades, A E ^a   Mavranezouli, Ifigeneia ^b   Dias, Sofia ^a   Welton, Nicky J ^a   Whittington, Craig ^b   Kendall, Tim ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL COLLEGE OF PSYCHIATRISTS   (United Kingdom)

Author keywords

antipsychotic medication; Markov model; meta analysis; mixed treatment comparisons; schizophrenia

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; PALIPERIDONE; PLACEBO; RISPERIDONE; ZOTEPINE;

ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; DATA ANALYSIS; DRUG EFFICACY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; META ANALYSIS; MONTE CARLO METHOD; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 78650107453     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2010.00784.x     Document Type: Article

References (24)

1. Nam I-S, Mengerson K, Garthwaite P,. Multivariate meta-analysis. Stat Med 2003; 22: 2309-33.
2. Riley RD, Abrams KR, Lambert PC, et al. An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes. Stat Med 2007; 26: 78-97.
3. Berkey CS, Anderson JJ, Hoaglin DC,. Multiple-outcome meta-analysis of clinical trials. Stat Med 1996; 15: 537-57.
4. Berkey CS, Hoaglin DC, Antczak-Bouckoms A, et al. Meta-analysis of multiple outcomes by regression with random effects. Stat Med 1998; 17: 2537-50.
5. Trikalinos T, Olkin I,. A method for the meta-analysis of mutually exclusive binary outcomes. Stat Med 2008; 27: 4279-300.
6. Gilks WR, Richardson S, Spiegelhalter DJ,. Markov Chain Monte Carlo in Practice. London: Chapman & Hall/CRC, 1996.
7. National Collaborating Centre for Mental Health. Schizophrenia: The NICE Guidelines on Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. Updated edition.Leicester & London: British Psychological Society and Royal College of Psychiatrists, 2010.
8. Cox DR, Oakes D,. Analysis of Survival Data. London: Chapman & Hall Ltd, 1984.
9. Lu G, Ades AE,. Assessing evidence consistency in mixed treatment comparisons. J Am Stat Assoc 2006; 101: 447-59.
10. Lumley T,. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21: 2313-24.
11. Higgins JPT, Whitehead J,. Borrowing strength from external trials in a meta-analysis. Stat Med 1996; 15: 2733-49.
12. Caldwell DM, Ades AE, Higgins JPT,. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005; 331: 897-900.
13. Spiegelhalter DJ, Best N, Carlin BP,. Bayesian deviance: the effective number of parameters, and the comparison of arbitrarily complex models. Division of Biostatistics: University of Minnesota, 1998.
14. Spiegelhalter DJ, Best NG, Carlin BP, et al. Bayesian measures of model complexity and fit. J R Stat Soc Series B Stat Methodol 2002; 64: 583-616.
15. Welton NJ, Ades AE,. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. Appl Stat 2005; 54: 385-404.
16. Spiegelhalter D, Thomas A, Best N, Lunn D,. WinBUGS user manual version 1.4 January 2003. Upgraded to Version 1.4.3. Available from: [Accessed July 20, 2010.
17. Brooks SP, Gelman A,. Alternative methods for monitoring convergence of iterative simulations. J Comput Graph Stat 1998; 7: 434-55.
18. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009; 373: 746-58.
19. Sweeting MJ, Sutton AJ, Lambert PC,. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004; 23: 1351-75.
20. Bradburn MJ, Deeks JJ, Berlin JA, Localio AR,. Much ado about nothing: a comparison of the performance of meta-analysis methods with rare events. Stat Med 2006; 26: 53-77.
21. Lu G, Ades A,. Modelling between-trial variance structure in mixed treatment comparisons. Biostatistics 2009; 10: 792-805.
22. Welton NJ, Ades AE,. Estimation of Markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis and model calibration. Med Decis Making 2005; 25: 633-45.
23. Lu G, Ades AE, Sutton AJ, et al. Meta-analysis of mixed treatment comparisons at multiple follow-up times. Stat Med 2007; 26: 3681-99.
24. Welton NJ, Cooper NJ, Ades AE, et al. Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B. Stat Med 2008; 27: 5620-39.